Digitisation | May 01, 2023
Aptar Digital Health and Healint collaborate for Central Nervous System
The partnership will capitalize on the combined capabilities of the two organizations
The partnership will capitalize on the combined capabilities of the two organizations
Initiative seeks innovative experimental and computational approaches to uncover neural circuits regulating immune function and identify novel therapeutic targets
The company plans an aggressive partnering push, with 62 pre-scheduled meetings over four days, focused on out-licensing, co-development, and strategic collaborations with global pharmaceutical and biotech players
Dr. Quirk said the program’s mechanism offers a targeted approach to disrupted brain signaling in compulsivity-related disorders
BPDCN typically presents with skin lesions before rapidly spreading to the bone marrow, lymph nodes
This positions its platform as a rapidly evolving engine for next-generation genetic medicine
Paves way for CNS cancer test rollout
The trials -- ELOWEN-1 and ELOWEN-2 -- are designed to evaluate the drug in people living with lupus who experience active skin manifestations
The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints
The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
